Biliary Gallbladder Cáncer

Abstract

Gall bladder cancer (CVB) is a rare disease in the world and highly lethal. In 1777, Maximillian de Stoll made the first description in the famous Vienna Clinic. Keen in 1891 performs the first resection. In 1978, Piehler and Crichlow wrote the first large CVB study demonstrating 5% survival (SV) in 5835 cases analysed). As early as 1931, Garretón Silva highlighted the high frequency of CVB when he described that in a series of 350 patients with acute cholecystitis, of them were affected by a malignant transformation. In most cases CVB is presented as an asymptomatic entity and only presents symptoms when there is advanced disease. The life forecast in all stages of the CVB is close to 5%. The average life in patients diagnosed incidentally is 26.4 months. The CVB can be 6 times more common in women than in men. The incidence increases with age and is diagnosed more frequently between the sixth and seventh decade of life.